EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors. Founded by Gregory Frost in 2015, Exuma Biotech is backed by BioAtla, MSD Partners, Americo Financial Life and Annuity, F1 BioVentures, and SunTerra Capital and is headquartered in Grand Cayman.
FOUNDED:
2015
INDUSTRY:
Big Data, Biotechnology, Health Care, Medical
FOUNDERS:
Gregory Frost
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
